PDF
CDR Summary Vol 30 #1 - Newfoundland and Labrador Immunization Coverage Report 2005-2012
Organization: Newfoundland Labrador Department of Health and Community ServicesPublished: 2013
Communicable Disease Report
Quarterly Report Volume 30, Number 1 - March 2013
Previous reports available:
Updated reports available:
- CDR Immunization Schedules July 2014 and VPDs Vol 31 #1
- CDR 2014 Year End Summary March 2015 Vol 32 #1
- CDR Immunization Schedule, Syphilis and TB June 2015 Vol 32 #2
- CDR Pertussis in NL 1991-2015; September 2015 Vol 32 # 3
- CDR TB, Vaccine Coverage, Hepatitis C, Vaccine Preventable Disease December 2015 Vol 32 #4
- CDR Influenza Vaccine and Surveillance June 2016 Vol 33 #2
Resource Group:
Background Knowledge
Product Type: Report
Vaccine Preventable Disease Surveillance
Provincial and Territorial Surveillance
Product Type: Report
Category:
Monitoring and Surveillance,Vaccine Preventable Disease Surveillance,Provincial and Territorial Surveillance Monitoring and SurveillanceVaccine Preventable Disease Surveillance
Provincial and Territorial Surveillance
Audience:
Health Care Professional
Population: School-aged Children
Region: Newfoundland and Labrador (NL)
Population: School-aged Children
Region: Newfoundland and Labrador (NL)
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.